financetom
Business
financetom
/
Business
/
Vistra's Q3 Net Income, Operating Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vistra's Q3 Net Income, Operating Revenue Rise
Nov 9, 2024 12:04 PM

07:31 AM EST, 11/07/2024 (MT Newswires) -- Vistra ( VST ) reported Q3 net income Thursday of $1.84 billion, up from $502 million a year earlier.

An analyst polled by Capital IQ expected $445.9 million.

Operating revenue for the quarter ended Sept. 30 was $6.29 billion, compared with $4.09 billion a year earlier.

Two analysts polled by Capital IQ expected $5.01 billion.

The company said its board approved a $1 billion increase to its share buyback program.

Vistra's ( VST ) shares were up over 2% in recent Thursday premarket activity.

Price: 129.03, Change: +2.94, Percent Change: +2.33

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Investcorp could consider listing in 3-5 years, eyes US retirement savings
Investcorp could consider listing in 3-5 years, eyes US retirement savings
Jan 24, 2025
DAVOS, Switzerland (Reuters) - Investcorp could consider a public listing in the next three to five years, its vice chairman said on Friday, as the Middle East's biggest alternative investment firm targets a doubling of its assets under management to $100 billion. Rishi Kapoor, who is also Investcorp's chief investment officer, told the Reuters Global Markets Forum that it could...
Novo Nordisk Reports Positive Results From 1b/2a Clinical Trial for Obesity Drug Amycretin
Novo Nordisk Reports Positive Results From 1b/2a Clinical Trial for Obesity Drug Amycretin
Jan 24, 2025
06:37 AM EST, 01/24/2025 (MT Newswires) -- Novo Nordisk ( NVO ) said Friday its phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and amylin receptor agonist designed for once-weekly subcutaneous administration showed positive results. Amycretin, developed for subcutaneous and oral administration, is intended as a treatment for obesity and type 2 diabetes. The trial, conducted in 125 adults...
Alphabet's Google Agrees to Combat Fake Reviews Amid CMA Investigation
Alphabet's Google Agrees to Combat Fake Reviews Amid CMA Investigation
Jan 24, 2025
06:33 AM EST, 01/24/2025 (MT Newswires) -- Alphabet's (GOOG) Google ( GOOG ) has agreed to take stronger measures to detect and remove fake reviews, UK's Competition and Markets Authority said Thursday. The agreement comes after the UK's Competition and Markets Authority launched an investigation into Google ( GOOG ) over concerns it may have been breaching consumer law by...
Market Chatter: Microsoft-backed OpenAI to be Exclusively Served by Stargate
Market Chatter: Microsoft-backed OpenAI to be Exclusively Served by Stargate
Jan 24, 2025
06:34 AM EST, 01/24/2025 (MT Newswires) -- Microsoft ( MSFT ) -backed OpenAI's ChatGPT will exclusively be served by Stargate, a high-profile artificial intelligence infrastructure project lauded by President Donald Trump this week, The Financial Times reported Friday, citing people familiar with the matter. The venture plans to spend $100 billion on big tech infrastructure projects, rising up to $500...
Copyright 2023-2026 - www.financetom.com All Rights Reserved